Resolution Therapeutics Employee Directory
Biotechnology ResearchScotland, United Kingdom51-200 Employees
Resolution Therapeutics is a clinical-stage biotechnology company focused on regenerative macrophage therapy to address inflammatory and fibrotic diseases. It originated in 2020 as a spin-out from the Forbes Lab within the University of Edinburgh's Centre for Regenerative Medicine and is based in Edinburgh, Scotland. The company's initial focus is end-stage liver disease, specifically advanced cirrhosis, where current options are limited to supportive care and liver transplantation. Resolution aims to develop a first-in-class treatment to help patients at risk of liver decompensation avoid transplantation. It operates within the biotechnology sector, pursuing regenerative macrophage therapies to modulate inflammation and fibrosis. In May 2026, the company disclosed preclinical data on its Regenerative Macrophage Therapy RTX001 at the ASGCT Annual Meeting, signaling progress in its program.
1-888-653-2347 
support@leadiq.com 
